1. Home
  2. VIR vs ATRO Comparison

VIR vs ATRO Comparison

Compare VIR & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ATRO
  • Stock Information
  • Founded
  • VIR 2016
  • ATRO 1968
  • Country
  • VIR United States
  • ATRO United States
  • Employees
  • VIR N/A
  • ATRO N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ATRO Military/Government/Technical
  • Sector
  • VIR Health Care
  • ATRO Industrials
  • Exchange
  • VIR Nasdaq
  • ATRO Nasdaq
  • Market Cap
  • VIR 844.9M
  • ATRO 844.1M
  • IPO Year
  • VIR 2019
  • ATRO N/A
  • Fundamental
  • Price
  • VIR $5.13
  • ATRO $33.69
  • Analyst Decision
  • VIR Strong Buy
  • ATRO Hold
  • Analyst Count
  • VIR 7
  • ATRO 1
  • Target Price
  • VIR $32.86
  • ATRO $32.00
  • AVG Volume (30 Days)
  • VIR 1.1M
  • ATRO 646.8K
  • Earning Date
  • VIR 07-31-2025
  • ATRO 07-31-2025
  • Dividend Yield
  • VIR N/A
  • ATRO N/A
  • EPS Growth
  • VIR N/A
  • ATRO N/A
  • EPS
  • VIR N/A
  • ATRO N/A
  • Revenue
  • VIR $20,861,000.00
  • ATRO $816,288,000.00
  • Revenue This Year
  • VIR N/A
  • ATRO $8.33
  • Revenue Next Year
  • VIR N/A
  • ATRO $5.89
  • P/E Ratio
  • VIR N/A
  • ATRO N/A
  • Revenue Growth
  • VIR N/A
  • ATRO 13.73
  • 52 Week Low
  • VIR $4.32
  • ATRO $14.13
  • 52 Week High
  • VIR $14.45
  • ATRO $36.32
  • Technical
  • Relative Strength Index (RSI)
  • VIR 48.62
  • ATRO 60.18
  • Support Level
  • VIR $5.00
  • ATRO $32.61
  • Resistance Level
  • VIR $5.35
  • ATRO $34.72
  • Average True Range (ATR)
  • VIR 0.24
  • ATRO 1.55
  • MACD
  • VIR 0.02
  • ATRO -0.35
  • Stochastic Oscillator
  • VIR 31.21
  • ATRO 28.20

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: